Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-000742
Filing Date
2013-06-27
Accepted
2013-06-27 16:58:24
Documents
1
Period of Report
2013-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3326
  Complete submission text file 0000904454-13-000742.txt   4739
Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address
CROSS ALEXANDER D (Reporting) CIK: 0001182619 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 13938047

Mailing Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112
Business Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112 206 325 6086
ATOSSA GENETICS INC (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus